Adolescent mental health pharmacological options expand
Adolescent-specific labels and indication expansions are creating real prescribing options for ADHD, anxiety, and depression in this population.
Adolescent mental health has been undertreated relative to adult mental health for decades. Adolescent-specific labels and indication expansions over the past 24 months have expanded the prescribing toolset for ADHD, anxiety, and depression in this population. The infrastructure question is whether adolescent psychiatry capacity matches the prescribing options.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.